Antibody complexes and methods for immunolabeling
AssigneeLife Technologies Corporation
InventorsRobert A. Archer, Joseph M. Beechem, David C. Hagen, Richard P. Haugland, Rosaria Haugland
Life of this patent
Estimating the term…
Loading patent…
AssigneeLife Technologies Corporation
InventorsRobert A. Archer, Joseph M. Beechem, David C. Hagen, Richard P. Haugland, Rosaria Haugland
Estimating the term…
The present invention provides novel immunolabeling complexes and certain components of such complexes, as well as methods of preparing and using such complexes, and kits for use in preparing labeling proteins and for immunolabeling. The pre-formed immunolabeling complexes of the invention comprise both a target-binding antibody and a labeling protein that contains covalently attached labels, where the labeling protein binds selectively and with high affinity to a selected region of the target-binding antibody. Novel labeling proteins of the invention include non-antibody peptides and proteins, such as a complex of protein G and a labeled albumin, and monovalent antibody fragments, such as labeled Fab fragments of an anti-Fc antibody. In methods of the invention, the preformed immunolabeling complexes are added to the sample alone or in combination, for purposes of labeling and optionally detecting the target of interest.
A method for determining the presence of a desired target in a biological sample, said method comprising:
A method for determining the presence of a desired target in a biological sample, said method comprising:
A method for determining the presence of a desired target in a biological sample, said method comprising:
An isolated immunolabeling complex consisting essentially of:
An isolated immunolabeling complex consisting essentially of:
An isolated immunolabeling complex consisting essentially of:
An isolated monovalent labeling protein consisting essentially of a monovalent fragment generated from an antibody and capable of binding selectively and with high affinity to a selected region of a second antibody, wherein said monovalent protein is covalently labeled with one or more labels, and which labels are optionally the same or different.
An isolated labeling mixture comprising one or more immunolabeling complexes, wherein at least one immunolabeling complex consists essentially of:
An isolated labeling mixture comprising one or more immunolabeling complexes, wherein at least one immunolabeling complex consist essentially of a target-binding antibody bound by a labeling protein that is a protein G complexed with albumin, wherein said albumin is covalently labeled with one or more labels, and which labels are optionally the same or different.
An isolated protein G complex consisting essentially of protein G and albumin, wherein said albumin is covalently labeled with one or more labels, which labels are optionally the same or different.
A kit for preparing an immunolabeling complex, said kit comprising:
A kit for preparing an immunolabeling complex, said kit comprising:
A kit for immunolabeling a desired target in a biological sample, said kit comprising:
A kit for immunolabeling a target in a sample, said kit comprising:
An isolated monovalent fragment for labeling antibodies made by the process comprising the steps of:
An isolated monovalent fragment for labeling target-binding antibodies made by the process comprising the steps of:
An isolated immunolabeling complex made by a process comprising:
A kit for preparing labeling proteins, said kit comprising:
Dependencies are inferred from the claim text.